A Prospective Observational Cohort Study to Monitor and Compare the Occurrence of Hypersensitivity Reaction and Hepatotoxicity in Patients Receiving Dolutegravir (with and without Abacavir) or other Integrase Inhibitors (with or without Abacavir) (201177)

08/10/2014
23/04/2024
EU PAS number:
EUPAS7597
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

201177-protocol-redact

English (554.73 KB - PDF) View document
Updated protocol

viiv-201177-protocol1-redact

First published: 22/02/2024
English (85.82 KB - PDF) View document
Study results
Study results

viiv-201177-clinical-study-report-final-redact

English (1.94 MB - PDF) View document
Study report
Study report

viiv-201177-clinical-study-report-redact

English (1.49 MB - PDF) View document

viiv-201177-clinical-study-report-redact-v02

English (1.04 MB - PDF) View document

viiv-201177-clinical-study-report1-redact

English (1.31 MB - PDF) View document
Other information
Study, other information

viiv-201177-clinical-study-report-redact-v02.pdf

English (1.04 MB - PDF) View document

viiv-201177-clinical-study-report1-redact.pdf

English (1.31 MB - PDF) View document